Adage Capital Partners Gp, L.L.C. Shattuck Labs, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $52.3 Billion
- Q2 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,745,000 shares of STTK stock, worth $9.58 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,745,000
Previous 2,370,000
15.82%
Holding current value
$9.58 Million
Previous $21.2 Million
49.99%
% of portfolio
0.02%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding STTK
# of Institutions
76Shares Held
26.8MCall Options Held
3.1KPut Options Held
23.9K-
Redmile Group, LLC San Francisco, CA5.62MShares$19.6 Million1.41% of portfolio
-
Prosight Management, LP Dallas, TX4.67MShares$16.3 Million5.63% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$8.64 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.3MShares$8.04 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.57MShares$5.48 Million0.0% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $148M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...